Search clinical trials for: Omiganan 1% gel

Total 17045 results

Maruho Co., Ltd.

Completed

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

Usual Type Vulval Intraepithelial Neoplasia (uVIN)

Netherlands
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Maruho Co., Ltd.
Leiden University Medical Center

Completed

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

Condylomata Acuminata (External)

Netherlands
Cadence Pharmaceuticals

Completed

Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects

Infection

United States
Maruho Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Rosacea

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Netherlands, Sweden
Maruho Co., Ltd.

Completed

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

Rosacea

United States, United Kingdom, Canada, New Zealand, Australia, France, Sweden, Netherlands
Cadence Pharmaceuticals

Completed

Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters

Infection

United States, Germany, France, Spain
Maruho Co., Ltd.

Completed

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

Healthy

Netherlands
Maruho Co., Ltd.

Completed

A Twelve Week Safety and Efficacy Study in Rosacea

Papulopustular Rosacea

United States
Maruho Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Rosacea

United States, France, United Kingdom, Germany, Canada, Netherlands, New Zealand, Australia, Sweden
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

Acne Vulgaris

Australia
Starpharma Pty Ltd

Completed

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

Recurrent Bacterial Vaginosis (BV)
Novan, Inc.

Completed

A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

Acne Vulgaris

Dominican Republic, Honduras, Panama
Aswan University Hospital

Not yet recruiting

Developmental Endothelial Locus-1, Platelet Count, and Soluble P-selectin in Overweight and Obese Subjects

Overweight and Obesity

Egypt
DermBiont, Inc.

Recruiting

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Non-Melanoma Skin Cancers

United States
Prism Pharma Co., Ltd.

Completed

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Systemic Scleroderma

United States
Starpharma Pty Ltd

Completed

A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis

Bacterial Vaginosis
Starpharma Pty Ltd

Completed

A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis

Bacterial Vaginosis
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

Rosacea | Papulopustular Rosacea

United States
DermBiont, Inc.

Terminated

A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis

Interdigital Tinea Pedis

Dominican Republic
Galderma R&D

Completed

Efficacy and Safety of CD5024 1% in Acne Vulgaris

Acne

France, Canada, Germany
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
University of Washington
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate (PROS-2)

Healthy

United States
bioRASI, LLC

Completed

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Papulopustular Rosacea | Erythematotelangiectatic Rosacea

United States
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections

Sepsis | Fungemia | Bacteremia

United States
Glia, LLC

Active, not recruiting

Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease

Ocular Graft-versus-host Disease

United States
Badr University

Completed

Tackling Pressure Ulcer Via Bee Venom Phonophoresis (ulcer)

Pressure Ulcers | Phonophoresis | Bee Venom

Egypt
GlaxoSmithKline

Completed

Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects

Acne Vulgaris

Japan
Government Dental College and Research Institute...

Completed

1% Metformin in Moderate and Severe Periodontitis

Periodontitis
Galderma R&D

Completed

Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Hoth Therapeutics, Inc.
Worldwide Clinical Trials

Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (CLEER)

Acneiform Eruption Due to Chemical | Xerosis Cutis | Paronychia

United States
Maruho Co., Ltd.

Completed

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Isfahan University of Medical Sciences

Completed

The Effect of Azithromycin in the Treatment of Chronic Periodontitis

Chronic Periodontitis

Iran, Islamic Republic of
Seno Medical Instruments Inc.

Suspended

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications

Breast Cancer

United States
BioPharmX, Inc.

Completed

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Acne Vulgaris

United States
Government Dental College and Research Institute...

Unknown

Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic Periodontitis

Intrabony Defects in Chronic Periodontitis

India
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

Post-menopausal Period
CONRAD
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

HIV Prevention

United States
GlaxoSmithKline

Completed

Study to Investigate the Irritation Potential of GSK1940029 Gel

Acne Vulgaris

Australia
CONRAD

Withdrawn

Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females

HIV Prevention

United States
Taro Pharmaceuticals USA

Completed

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea (MTZG)

Rosacea

United States
CONRAD

Withdrawn

Paper Applicator Acceptability Study

HIV Prevention

South Africa
BioPharmX, Inc.

Completed

BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris (OPAL)

Acne Vulgaris

United States
Dr R Viswa Chandra

Recruiting

Efficacy of Insulin Like Growth Factor-1(IGF-1) on Bone Regeneration in Intrabony Defects : A Clinico-radiograph Study

Intrabony Periodontal Defect

India
University of Colorado, Denver
National Institute of Neurological Disorders and Stroke (NINDS); Children's... and other collaborators

Completed

Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome (TestoXXY/KS)

Klinefelter Syndrome | XXY Syndrome

United States
Galderma R&D

Completed

Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Riphah International University

Completed

Comparing the Efficacy of Metronidazole and Minocycline Gels for the Treatment of Diabetic Periodontitis Patients

Diabetes Mellitus | Periodontitis

Pakistan
Universidad Autonoma de Nuevo Leon

Completed

Metabolic Syndrome and Functional Food

Metabolic Syndrome

Mexico
GlaxoSmithKline

Completed

DUAC® Early Onset Efficacy Study in Japanese Subjects

Acne Vulgaris

Japan
BioSante Pharmaceuticals

Completed

Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada

3

Subscribe